Clinical Trial Update: Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating isotretinoin, interferon alfa-2b, and paclitaxel for stage IV, recurrent, or persistent cervical cancer was terminated, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)
• Interferon-alpha-2b (interferon alfa-2b)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Cervical Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-11-20